Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Opthea Limited ( (AU:OPT) ) has shared an update.
Opthea Limited has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). The company will be quoting 4,662 ordinary fully paid securities, with the issue date recorded as February 14, 2025. This move may impact Opthea’s market presence and provide stakeholders with additional investment opportunities.
More about Opthea Limited
Opthea Limited operates in the biotechnology industry, primarily focusing on the development of therapies for eye diseases. The company is dedicated to advancing the treatment of conditions such as wet age-related macular degeneration and diabetic macular edema.
YTD Price Performance: 9.09%
Technical Sentiment Consensus Rating: Hold
For an in-depth examination of OPT stock, go to TipRanks’ Stock Analysis page.
